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Evolutionary studies on dengue virus have frequently focused on intra-serotype diversity or on speciﬁc
epidemics. In this study, we compiled a comprehensive data set of the envelope gene of dengue virus ser-
otypes and conducted an extensive comparative study of evolutionary molecular epidemiology. We
found that substitution rates are homogeneous among dengue serotypes, although their population
dynamics have differed over the past few years as inferred by Bayesian coalescent methods. On a global
scale, DENV-2 is the serotype with the highest effective population size. The genealogies also showed
geographical structure within the serotypes. Finally, we also explored the causes of dengue virus serotype
diversiﬁcation by investigating the plausibility that it was driven by adaptive changes. Our results sug-
gest that the envelope gene is under signiﬁcant purifying selection and the hypothesis that dengue virus
serotype diversiﬁcation was the result of stochastic events cannot be ruled out.
 2011 Elsevier B.V.Open access under the Elsevier OA license. 1. Introduction
Dengue is an arthropod-borne disease that affects 50–100 mil-
lion people per year in tropical and subtropical regions, resulting
in death rates between 0.03% and 1.4% (WHO, 2005). Dengue virus
(DENV) is a positive-sense single-stranded RNA (ssRNA+) Flavivirus
transmitted bymosquitos of the genus Aedes. Dengue virus exists as
four antigenically different serotypes (DENV-1–4), with uncertain
evolutionary origins (Holmes and Burch, 2000). Within the sero-
types, several authors have also characterized genotypes, based
on genetic diversity and geographical distribution (Araujo et al.,
2009; Klungthong et al., 2008; Kukreti et al., 2009; Rico-Hesse,
1990; Vasilakis et al., 2007).
Evolutionary studies of DENV are abundant. However, works
have focused on the inference of substitution rates and the intra-
serotype phylogeny (Goncalvez et al., 2002; Lanciotti et al., 1997,
1994; Twiddy et al., 2002a). It has been shown that evolutionary
lineages within serotypes generally present characteristic geo-
graphical structure that reﬂects the spatial dynamics of epidemics
(Holmes, 2008; Zhang et al., 2005). Dengue virus substitution rates,
mainly measured from the envelope protein gene (E), have been
estimated using several methodological approaches and are com-
parable to the evolutionary rates of other RNA viruses (Twiddy
et al., 2002b; Wang et al., 2000).de Genética, A2-092, Inst.
iro, Ilha do Fundão, Rio de
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r OA license. Epidemiological surveys of dengue were conducted throughout
the last century and, until recently, these were the only data avail-
able for obtaining historical information about the spread of the
dengue virus (Gubler, 1998). Such surveys are essential for design-
ing effective public health policies. However, the genetic history of
the virus is as important as traditional epidemiological surveillance
for understanding the full picture of epidemics (Bennett et al.,
2010). This is because genetic material harbors information that
can be used to reconstruct the history of epidemics in time and
space. Moreover, recent coalescence techniques have also permit-
ted the inference of population parameters such as growth rate
and the effective number of infections (Drummond et al., 2003).
Several works have applied these methods to tackle DENV evo-
lution (Bennett et al., 2010; Mondini et al., 2009; Villabona-Arenas
and Zanotto, 2011). However, these studies focused on speciﬁc ser-
otypes and an extensive comparative analysis is still lacking. A
comparative analysis of dengue serotypes is important because
there is increasing evidence that their epidemic potentials are dif-
ferent and that episodes of secondary infection with different ser-
otypes frequently result in higher morbidity rates caused by the
severe forms of the infection (Guzman et al., 2007).
Moreover, the causes of dengue serotype diversiﬁcation are still
unclear (Twiddy et al., 2002a). It has been suggested that the four
serotypes originated from independent zoonotic passage to hu-
mans (Vasilakis et al., 2011). If this was so, we would expect that
the DENV lineages have adapted to the new host and, conse-
quently, there would be signatures of positive selection along the
DENV genome. However, studies involving the estimation of dN/dS
ratios on the envelope gene revealed extensive purifying selection
(Holmes, 2003; Klungthong et al., 2004; Zhang et al., 2006).
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ative analysis of the history of dengue virus serotypes as inferred
from a large number of publicly available sequences from the last
few decades. By using coalescent-based approaches in a Bayesian
framework, we assessed the demographic dynamics of epidemics
throughout the last few centuries and estimated evolutionary
parameters relevant for understanding the evolutionary aspects
of DENV serotype emergence. We have also investigated the occur-
rence of adaptive molecular evolution on the emergence of DENV
serotypes as well as the heterogeneity of selective forces along
the envelope gene.2. Materials and methods
2.1. Data set
We have downloaded all envelope gene sequences, which codes
for the envelope protein, available in GenBank that contained
information on the collection date, geographical location and that
comprised the whole gene sequence. Then, a data set was com-
posed of 596 sequences sampled to obtain the maximum geo-
graphical and chronological diversity (Table 1). This was achieved
by excluding sequences collected in the same year from the same
geographical location. Recombining sequences were excluded from
the data set after inspection in the RDP3 program (Martin et al.,
2010), using the RDP method (Martin and Rybicki, 2000). This sam-
pling was performed to permit the implementation of sophisti-
cated evolutionary analyses, which are unfeasible to be run on
large amount of sequences. The data set covers a temporal range
of 64 years (1944–2008) from 71 countries and consists of the larg-
est DENV data set compiled to date. Sequences were aligned in Clu-
stalW and inspected in MEGA 4.1. The ﬁnal alignment included
1485 nucleotides. A list of access numbers is provided as supple-
mentary information. The alignment used is available from the
authors upon request. Analyses were conducted on each serotype
independently and on the full data set.2.2. Evolutionary rates and genealogical analysis
The comparative analysis of the DENV serotypes consisted of
inferring the genealogy of the serotypes and the historical dynam-
ics of the epidemics. We also investigated the action of differential
selective forces along the envelope gene. Nucleotide substitution
model choice was performed in HyPhy (Pond et al., 2005) and
the GTR + G was selected since it signiﬁcantly increased the likeli-
hood of the data. All coalescent-based analyses were conducted in
BEAST 1.6.1 (Drummond and Rambaut, 2007), which implements a
Bayesian inference of evolutionary parameters via the Markov
chain Monte Carlo (MCMC) method. The chronology of the dengue
virus diversiﬁcation was estimated using the relaxed molecular
clock, in which the priors for the evolution of rates among
branches were assumed to follow an uncorrelated lognormal dis-
tribution. The Bayesian skyline was the tree topology coalescent
prior applied, since there is no indication whether the effective
population size of DENV serotypes follow simple demographic
models (i.e., constant, exponential or logistic growth). DuringTable 1
Characteristics of DENV data set used in this study.
Serotype Number of sequences Number of countries Time intervals
DENV-1 139 39 1944–2008
DENV-2 206 47 1944–2008
DENV-3 161 37 1956–2008
DENV-4 90 28 1956–2008MCMC, the parameters were visited for 50,000,000 generations
and sampled every thousand cycles, resulting in 50,000 topologies
and associated parameters. Of these, 10% were discarded as burn-
in. Convergence of the MCMC run was checked in TRACER by
inspecting the trace plots and calculating the effective sample
sizes. To reconstruct the dengue virus demographic history, we
employed the Bayesian skyline plot (BSP) model (Drummond
et al., 2003, 2005), which generates piecewise constant population
size trajectories. In order to test the robustness of the estimates of
effective population sizes of serotypes to the number of sequences
analyzed, we have composed an additional data set in which DEN-
Vs-1, 2 and 3 samples were reduced to 90 randomly chosen se-
quences. Note that this is also the number of sequences present
in the smallest data set (DENV-4).
2.3. Differential selection along codon sites
Analysis of differential selective pressures along codon sites of
the envelope gene was conducted in the CODEML program of the
PAML 4.4 package (Yang, 2007) by calculating codon-speciﬁc dN/
dS values (the x parameter). Alignments of each DENV serotype
were tested for positive selection independently, and jointly, using
the M1a–M2a, the M7–M8 and the M8–M8a models (Wong et al.,
2004). A qualitative measure of the distribution of x values along
codon sites in DENV serotypes was obtained by plotting the beta
distribution with the parameters inferred by the M7 model (Yang
et al., 2000). A comparison of the strength of selection along the
envelope gene among the serotypes was conducted using the ap-
proach of Choisy et al. (2004), who used a paired Wilcoxon rank
sum test to verify whether or not the weighted x for each codon,
estimated under the discrete M3 model (Yang et al., 2000), signif-
icantly differed between serotypes. Finally, the SLAC and the FEL
algorithms (Pond and Frost, 2005) of the HyPhy package (Pond
et al., 2005) were also used to access codons under positive selec-
tion in DENV serotypes independently and on the joint data set.
2.4. Differential selection on internal branches of DENV phylogeny
In order to investigate the action of adaptive molecular evolu-
tion on the diversiﬁcation of dengue serotypes, we allowed inter-
nal branches of the phylogeny containing all DENV serotypes
(Fig. 1) to evolve under different dN/dS ratios using the approach
described in Yang (1998), implemented in the PAML 4.4 package.
We have also run the IFEL test of HyPhy (Pond et al., 2006) and
the newly proposed branch-site test of episodic diversifying selec-
tion (Kosakovsky Pond et al., 2011), available at www.datamon-
key.org, which permits the inference of lineage-speciﬁc events of
positive selection. These analyses were conducted to verify
whether the hypothesis of diversiﬁcation lead by genetic drift
(founder effects) could be rejected.
2.5. Analysis of geographic correlation and ancestral states
In order to understand the spatial dynamics of DENV evolution
comparatively, we have veriﬁed the association between phylog-
eny and geography for each serotype independently. This test
was conducted in Beﬁ-BaTS, v0.1.1 (Parker et al., 2008), which
implements several tests of phylogeny–trait correlation consider-
ing phylogenetic error. We have inferred the parsimony score
(PS), the association index (AI) and the monophyletic clade size
statistics to test phylogeny–geography correlation. As geography
traits, we have considered the continent where the samples were
obtained. The reconstruction of the ancestral geographical states
was implemented in Mesquite 2.7 (Maddison and Maddison,
2009) using the parsimony algorithm.
Fig. 1. DENV virus phylogeny, picturing the evolutionary afﬁnities of the serotypes. Numbers on nodes indicate the TMRCA of the clades (years before 2008). Bars depict the
95% HPD intervals of the time estimates. The posterior probabilities of all clades are 100%.
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3.1. History and geography of dengue virus
The four serotypes of DENV were clearly arranged in well-de-
ﬁned clades with maximum statistical support (Fig. 1). The time
to the most recent common ancestor (TMRCA) of all of the dengue
serotypes, and also the time of the split of the DENV-4 lineage, was
estimated at 1672 years ago, i.e., in the fourth century (Table 2).
The 95% highest probability density (HPD) interval, however, was
wide ranging from 2294 to 1158 years ago. It is interesting to note
that the earliest records of an illness clinically similar do dengue
fever are from the Chin dynasty of China, between the third and
ﬁfth centuries (Gubler, 1998), which is close to our mean estimate
for the TMRCA of all serotypes. The serotype with the oldest coales-
cence time was found to be DENV-2, at ca. 340 years ago. Again,
our estimates are in agreement with the historical records of the
ﬁrst outbreaks of illnesses that were clinically similar to dengue
in the Americas (French West Indies and Panama) at the end of
the seventeenth century (Gubler, 1998). Such estimates indicate
that the events that gave rise to the serotypes had already occurred
before the year 1650, as we inferred.
DENV genealogy revealed signiﬁcant geographical structure
(Fig. 2, Supplementary material). For all serotypes, the PS and AI
tests were signiﬁcant (p-value <0.01). However, the monophyletic
clade size statistics was different for each serotype. For DENV-1
and DENV-2, the clade statistics recovered signiﬁcant trait associ-
ation for America and Asia. DENV-4 is also structured for all sam-
pled continents (Asia and Americas) except for Oceania, however
this serotype did not included any samples from Africa, while
DENV-3 diversity is structured for all sampled continents except
for Africa. The absence correspondent geographical structuring
among serotypes implies differential migration during the evolu-
tionary history of DENV. The geographical association revealed in
this study is not associated with chronological sampling bias, i.e.,
sequences came from a particular outbreak, because they were col-Table 2
Time to the most recent common ancestor and evolutionary parameters of
Serotype TMRCA (years ago) Subs
DENV-1 102.9 (88.6–119.2) 7.5 (
DENV-2 338.1 (227.1–462.9) 7.5 (
DENV-3 108.9 (87.5–132.6) 8.2 (
DENV-4 203.4 (116.4–295.7) 7.8 (
Joint 1672.1 (1158.4–2294.7) 7.6 (lected at different time intervals. This indicates that, at a given
time point, the probability is high that the ancestral lineage of
the sample existed in the same geographic region. However, the
global geographical structure within serotypes must be thoroughly
tested by increasing the number of samples from Africa and Ocea-
nia, continents that are poorly available in public databases. Based
on the data we have collected, the dynamics of dengue epidemics
is fundamentally restricted by geographical distance at the conti-
nental level (Twiddy et al., 2002a).
Except for DENV-3, the ancestral state reconstruction points
parsimoniously to an Asian origin for all serotypes. In DENV-3,
an American origin is equally parsimonious. Early historical re-
cords of dengue epidemics in the Americas, supposedly a result
of the slave trade, and the incidence of DENV in African monkeys
would lead to an African origin. However, an Asian origin is consis-
tent with the geographical occurrence of the sylvatic cycle of DEN-
Vs 1–4, while only sylvatic DENV-2 was reported in Africa
(Vasilakis et al., 2011).3.2. Rates of molecular evolution
The global rate of molecular evolution of the envelope gene of
dengue virus was inferred as 7.6  104 substitutions/site/year
(s/s/y) (Table 2). Substitution rates were very homogeneous among
the serotypes: DENV-1 and DENV-2 presented an average of
7.5  104 s/s/y, while for DENV-3 and DENV-4 the values were
estimated as 8.2  104 and 7.8  104 s/s/y, respectively. The
95% HPD interval of the estimates did not allow the rejection of
the hypothesis that substitution rates on the envelope gene are
the same among the serotypes. Within the serotypes, homogeneity
of evolutionary rates along branches of the tree, which character-
izes the molecular clock, could not be observed (Table 2). The
95% HPD interval of the estimate of the coefﬁcient of variation of
the serotypes did not contain 0, thus, the strict clock was not
appropriate for these data. Although our estimates are in agree-
ment with previous studies (Carrington et al., 2005; JenkinsDENV.
titution rate (104 s/s/y) Coefﬁcient of variation
6.6–8.4) 0.3 (0.2–0.5)
6.0–8.6) 0.4 (0.3–0.5)
7.2–9.1) 0.4 (0.2–0.5)
6.3–9.5) 0.4 (0.3–0.6)
6.6–8.7) 0.4 (0.3–0.4)
Fig. 2. Bayesian skyline plot of the past population dynamics of the four serotypes of dengue virus. Solid black line: full data set, dashed black line: reduced data set. Grey
areas correspond to the 95% HPD intervals of the full data, blue areas correspond to the 95% HPD intervals of the reduced data. The effective population size (y-axis) is
measured by the product of the effective population size (Ne) and virus generation time (g).
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et al. (2003) reported slower substitution rates for DENV-1
(4.6  104 s/s/y) and Klungthong et al. (2004) inferred a faster rate
for DENV-4 (10.7  104 s/s/y). These differences are, however,
possibly not signiﬁcant, since these studies used different methods
and different sequence samplings. For instance, Klungthong et al.
(2004) surveyed only DENV-4 genotype I sequences from Thailand.
3.3. Population dynamics
While the dengue serotypes were found to be similar in mea-
sures of substitution patterns over time, the population dynamics
of these lineages differed in both the complete and reduced data
sets (Fig. 2). The phylodynamics of the serotypes are best recorded
over the last 50 years. In the complete data set, DENV-1 serotype
presented three periods in which the effective population size, as
measured by the product of the effective population size and gen-
eration time, increased – the beginning of the 1970s, the 1980s and
by the year 2000. The phylodynamic pattern inferred for DENV-2
exhibited periods of a rapid increase in the effective population
size (the early 1980s and early 2000s). An abrupt increase in the
effective population size in the early 2000s also characterized theevolution of DENV-3. Finally, DENV-4 displayed an interesting pat-
tern. The effective population size of this serotype expanded dur-
ing the 1980s. By the mid-1990s, however, its population size
had decreased. The DENV-4 serotype was the only one that pre-
sented such a tendency. For all of the other serotypes, the popula-
tion size increased dramatically since the early 2000s. Such
increase is probably associated with increased of human popula-
tion movement as well as uncontrolled growth of mosquito popu-
lation. Also, commercial routes, which might spread mosquito eggs
in diapause, may contribute to the recent increase in DENV effec-
tive population size worldwide.
DENV-2 is the serotype with the highest effective population
size, followed by DENV-3, DENV-1 and DENV-4. Therefore, on a
global scale, DENV-2 is the epidemiologically most relevant sero-
type. The signiﬁcant increase of the population size of DENV sero-
types 1–3 is corroborated by the data from the dengue incidence
from public health agencies (e.g., http://www.who.int/mediacen-
tre/factsheets/fs117/en). Such correlation corroborates the recent
ﬁndings of Bennett et al. (2010), who showed that the cyclic pat-
tern of DENV-4 epidemic in Puerto Rico is correctly inferred by
the BSP. Interestingly, Villabona-Arenas and Zanotto (2011) also
conducted the BSP analysis on global sequences of DENV-4 and
Table 3
Tests of positive selection in DENV virus serotypes and in the joint data set. 2DlnL, the
likelihood ratio test statistic. PSS, positively selected site.
M1a–M2a M7–M8 M8–M8a SLAC FEL
DENV-1 2DlnL = 0.0 2DlnL = 1.6 2DlnL = 0.0 PSS = 0 PSS = 0
DENV-2 2DlnL = 0.0 2DlnL = 5.1 2DlnL = 0.0 PSS = 0 PSS = 0
DENV-3 2DlnL = 0.0 2DlnL = 21.1*** 2DlnL = 0.1 PSS = 0 PSS = 2
(132, 380)
DENV-4 2DlnL = 0.0 2DlnL = 14.8*** 2DlnL = 2.9* PSS = 0 PSS = 1 (108)
Joint 2DlnL = 0.0 2DlnL = 0.2 2DlnL = 0.0 PSS = 0 PSS = 1 (228)
* 0.01 < p-value < 0.05.
*** p-value < 0.001.
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tive population growth over the last decate (GI is increasing, while
GII is decreasing). Our analysis, thus, inferred DENV-4 growth as
nearly constant over the same period. Therefore, a detailed analysis
of the genotypes within DENV serotypes will lead to a ﬁner picture
of dengue evolution.
The historical dynamics of the effective population size of DENV
serotypes should be interpreted with caution. When the sample
size was reduced to 90 sequences, the phylodynamics inferred
for DENVs 1, 2 and 3 differed. Although there still exists a cyclic
pattern of population expansion and contraction during the last
50 years, the accelerated growth rates during the last decade of
DENV-2 and DENV-3 were not recovered in the reduced data set
(Fig. 2b). This indicates that the robustness of the BSP analysis to
virus sequence sampling should be further explored.3.4. Selection analysis and the causes of dengue diversiﬁcation
The average dN/dS values over all codons of the envelope gene
were similar in all of the serotypes and all estimates were signiﬁ-
cantly lower than one, varying from 0.06 to 0.07, which implies the
action of negative selection, as previously documented (Holmes,
2003). The parameters of the beta distribution, used to model the
probability of x values along the sequence sites (M7 model), re-
sulted in distributions of similar shapes between DENV-1 and
DENV-2 and between DENV-3 and DENV-4 (Fig. 3). The DENV-3
and 4 serotypes presented a group of sites with a higher probabil-
ity of being assigned to x values close to one, indicating the relax-
ation of negative selection. However the highest density of the
distribution was found when x assumed values <1.
In nearly all DENV serotypes, the M1a–M2a, M7–M8 and M8–
M8a tests of positive selection on codon sites failed to reject the
null models in which the x > 1 category is absent (Table 3). In fact,
the log-likelihoods of the models M1a and M2a were identical in
all of the comparisons performed. A similar pattern was found in
M8–M8a comparisons. However, the M7–M8 model comparisons
in DENV-3 and DENV-4 indicated the existence of positive selec-
tion in these lineages, and the M8–M8a comparison could not re-
ject the null hypothesis of absence of positive selection in DENV-
4. The SLAC test of HyPhy also failed to estimate codon sites under
positive selection in serotypes and in the joint data set (Table 3).
The FEL algorithm inferred sites with x > 1 in DENV-3, DENV-4
and the joint data set.
Therefore, the null hypothesis of absence of positively selected
codon sites in DENV serotypes could not be rejected by all testsFig. 3. Probability distribution of the x values for codon sites along the envelope
gene, as modeled by the Beta distribution (M7). Dashed black line: DENV-1; solid
grey line: DENV-2; solid black line: DENV-3 and dashed grey line: DENV-4.implemented. Thus, there is no undisputed evidence of adaptive
molecular evolution occurring along codon sites of the envelope
gene. The tests that rejected positive selection, the M1a–M2a mod-
el comparison and the SLAC analysis, are subjected to lower type I
error rates (Pond and Frost, 2005). Thus, we prefer to assume that
the evidence of positive selection within DENV lineages is scant be-
cause it is not detectable by all methodologies available. Moreover,
the Wilcoxon test failed to reject the null hypothesis that the
strength of selection was homogeneous along the envelope gene
among the serotypes, which further corroborates that codon sites
of the envelope gene are, in general, under strong purifying
selection.
With respect to branch-speciﬁc dN/dS analyses, we also found no
evidence of adaptive molecular evolution acting on the basal diver-
siﬁcation of dengue virus serotypes. In CODEML, although the null
hypothesis of a single dN/dS for all branches of the dengue tree was
rejected in favor of the alternative hypothesis that the basal
branches had distinct dN/dS values, the ratio inferred for the basal
branches was very small (0.003); it was actually smaller than the
value estimated for the inside-serotype branches (0.054). This fur-
ther indicates that global positive selection did not act signiﬁcantly
during divergence of the serotypes as revealed by the E gene. In
HyPhy, the IFEL analysis could not differentiate dN/dS values along
the internal and terminal branches and the branch-site test of epi-
sodic diversifying selection also did not inferred any branch under
dN/dS > 1. Therefore, our results indicate that the emergence of
DENV serotypes was probably led by stochastic events (founder ef-
fects) followed by periods of geographical isolation. Such a sce-
nario was also proposed to explain the evolution of HIV-1 M
subtypes (Rambaut et al., 2004).
Studies of adaptive molecular evolution on DENV are not abun-
dant. Previous analyses that found evidence of positive selection on
the envelope gene were conducted mainly on DENV-2 (Bennett
et al., 2006; Twiddy et al., 2002a,b), and they indicated a few sites
under positive selection. Here, no codon site was inferred with
P > 95% at the x > 1 category in DENV-2. Actually, the M1a model
could not be rejected for all serotypes. One explanation for such
discrepancy is that the augmented sample size, including se-
quences from all over the world and from different time periods,
reduced the rate of false positives, which are known to be an issue
with maximum likelihood tests of selection (Suzuki and Nei, 2004).
Another hypothesis is that the global sample masked intra-geno-
type events of adaptive evolution, especially in the passage from
the sylvatic to the human cycle. However, as already reported by
Twiddy et al., 2002a, at least for DENV-2, there is no evidence of
adaptive evolution in the E gene during this event.
In conclusion, the present study has conducted a broad com-
parative investigation of the evolutionary epidemiology of dengue
serotypes by means of the analysis of the envelope gene. We
have shown that evolutionary rates are statistically identical in
all serotypes and that the E gene codon sites are under purifying
selection. No evidence of adaptive molecular evolution was found
on the basal branches of the DENV phylogeny, which suggests
314 R.L. Costa et al. / Infection, Genetics and Evolution 12 (2012) 309–314that early serotype diversiﬁcation can be the result of founder ef-
fects. DENV genetic diversity presents geographic structure on a
global scale. Such picture indicates that DENV spatial dynamics
is limited. Finally, the effective population sizes of DENV-1, 2
and 3 have increased since the early 2000s. DENV-2 is the sero-
type with the highest global growth rate over the last decade,
while DENV-4 has kept the effective population size nearly con-
stant during the same period. However, effective sample size
inference should be interpreted with caution, since we have dem-
onstrated that the analysis is not robust to the sampling of virus
sequences.
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